Cancer Clinical Trials in Lebanon, New Hampshire

4 studies are recruiting for cancer in Lebanon, New Hampshire right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Pan Tumor Rollover Study

    Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Local Institution - 0014, Lebanon, New Hampshire
    Locations
    399 in total
    Run by
    Bristol-Myers Squibb

    See if you can join NCT03899155 on ClinicalTrials.gov

  2. A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

    The goal of this clinical trial is to test CPO301, a type of drug called an antibody drug conjugate in adult patients with advanced or metastatic solid tumors. The main questions it aims to answer are: * To assess the safety and tolerability of CPO301 at increasing doses and determine the dose to b…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire
    Locations
    14 in total
    Run by
    Conjupro Biotherapeutics, Inc.

    See if you can join NCT05948865 on ClinicalTrials.gov

  3. Immune Profiling for Cancer Immunotherapy Response

    In patients clinically treated with FDA-approved immunotherapy the investigators will assess the predictive value of pre- and on-treatment 1) immune-methylation profiling across cancer types, and 2) immune-methylation profiling and cytokine profiling within cancer types.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
    Run by
    Dartmouth-Hitchcock Medical Center

    See if you can join NCT06116032 on ClinicalTrials.gov

  4. CAncer TReatment INformed by the Molecular Tumor Board At Dartmouth

    This is a single-arm Phase II study to measure the impact of Molecular Tumor Board treatment recommendations on treatment decision-making in clinical practice at the Dartmouth Cancer Center. Following tumor genetic profiling, subjects will be screened for eligibility. Eligible subjects' cases will …

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
    Run by
    Dartmouth-Hitchcock Medical Center

    See if you can join NCT05405413 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.